Prospa share price sinks 15% as online lender announces COVID provisions

The Prospa Group Ltd (ASX: PGL) share price sunk 15% at the open this morning after the online lender released its unaudited results.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Prospa Group Ltd (ASX: PGL) share price sunk 15% at the open this morning after the online lender released its unaudited results. Prospa is forecasting lower growth over FY20 as well as making additional provision for credit losses due to the impacts of COVID-19

Prospa shares have since regained some of their losses to be trading 7.65% down at the time of writing.

What does Prospa do?

Prospa is an Australian online business lender. Customers can borrow up to $300,000 with a 10-minute application, with funding available in as little as 24 hours.

Prospa first listed on the ASX last year at an offer price of $3.78. The Prospa share price fell to 75 cents this morning but has since recovered slightly and is now sitting at 84 cents. 

What did Prospa report?

Prospa's unaudited results show a material impact from the coronavirus-induced economic downturn. The lender reports its loan originations have decreased, while provisioning for credit losses has increased. Total loan originations were materially impacted in April and May, but did pick up meaningfully in June. 

Prospa provided 5,501 customers with COVID-19-related relief packages between 1 March and 31 May 2020. These were typically full deferrals of 6 weeks duration or partial deferrals for 12 weeks. Interest during the deferral periods was capitalised. 

The environment remains challenging for Prospa's small business customers. As a result, the company has set aside a $20 million provision to take into account the impact of the COVID-19 pandemic. An additional $5.5 million is being written off following a review of loan book receivables. 

The above provisions have contributed to an expected earnings loss before interest, tax, depreciation, and amortisation (EBITDA) of $18 million to $22 million. Prior to these adjustments EBITDA was expected to be $4 million to $8 million for FY20. Revenue grew at an annualised rate of 10% over the 9 months to March. This slowed abruptly with the onset of the pandemic, meaning Prospa now expects its FY20 growth to be around 4%. 

What is the outlook for Prospa? 

Prospa says it is seeking to support its small business customers to rebuild and invest for the future. The company is an approved lender under the SME Guarantee Scheme. This scheme has been extended to 30 June 2021 by the Federal Treasurer to support small business recovery. Prospa continues to provide customer relief packages but reports the volume of customer support requests has returned to pre-COVID levels. 

Prospa says it adapted quickly to the challenge of supporting customers as they navigate this period of economic uncertainty. The company says it sees customers across all sectors planning for their recovery.

Prospa's full-year results will be announced on 27 August. The Prospa share price is trading at 84 cents per share at the time of writing, which is down more than 80% on this time last year.

Motley Fool contributor Kate O'Brien has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A woman presenting company news to investors looks back at the camera and smiles.
Broker Notes

More of the best ASX stocks to buy in 2025 according to Bell Potter

Let's see why its analysts are so bullish on these stocks this year.

Read more »

Person pointing at an increasing blue graph which represents a rising share price.
52-Week Highs

5 ASX All Ords shares starting the new year at 52-week highs

What a way to start 2025...

Read more »

a group of five women in business attire stand side by side with unhappy looks on their faces and holding their thumbs down.
Share Fallers

5 worst ASX All Ordinaries shares of 2024

Shareholders of these ASX All Ordinaries stocks endured a teeth-gritting year.

Read more »

A happy male investor turns around on his chair to look at a friend while a laptop runs on his desk showing share price movements
Broker Notes

Goldman Sachs says these ASX 200 shares are buys

Let's see what the broker is saying about these big names.

Read more »

Broker looking at the share price.
Share Market News

5 things to watch on the ASX 200 on Friday

The benchmark index is expected to end the week in the red.

Read more »

A woman wearing headphones looks delighted and animated on news she's receiving from her mobile phone that she is holding close to her face.
Share Gainers

Why Brainchip, Fortescue, Mesoblast, and QBE shares are racing higher today

These shares are starting the year in a positive fashion. But why?

Read more »

a man weraing a suit sits nervously at his laptop computer biting into his clenched hand with nerves, and perhaps fear.
Share Fallers

Why Catapult, DroneShield, Lendlease, and Weebit Nano shares are sinking today

These shares are starting the year in the red. What's happening?

Read more »

group of friends jump on the beach
Broker Notes

6 ASX All Ords shares lifted to 'strong buy' consensus ratings for the new year

Brokers upgraded these ASX stocks last month.

Read more »